Technological innovations have enabled the adoption of decentralized and hybrid clinical trial models (DCTs) at scale. DCTs make clinical trial participation more accessible to more participants, allowing for remote data collection and greatly reducing or outright eliminating the need for in-person clinical visits.
For these reasons, this segment of clinical research is growing rapidly and many sponsors and CROs are now taking advantage of the ability to remove geographic constraints to expand the participant recruitment footprint for their studies while improving the experience for participants. Still, there persists the notion that this kind of expansion will make trials more expensive.
The truth is that the more study leaders utilize DCT approaches to expand access to eligible patients and introduce new efficiencies into studies, the more costs they can remove, thus reducing research costs overall. Following are five ways in which DCT approaches can help to save money.